Centauri welcomes scientists to the team
Centauri is delighted to welcome Bailey Hairsine and Sana Mobeen to the scientific team. Reporting to Dr Helen Bright, Bailey and Sana will undertake in vitro research into new antimicrobial treatments at the company’s Alderley Park site.
Centauri opens lab at Alderley Park
Centauri Therapeutics has taken a laboratory lease on Alderley Park and looks forward to research operations commencing shortly.
Centauri story featured in Sunday Times
Centauri's story through an interview with CSO Dr Mike Westby was featured in a Sunday Times article written by Sabah Meddings.
Centauri awarded follow-on CARB-X grant
Centauri Therapeutics Limited, an immunotherapy company focused on the treatment of infectious diseases, has been awarded a grant of up to $2.7 million USD (c.£2…
Centauri welcomes Dr Mike Westby, Chief Scientific Officer and Pamela Brown, Head of Chemistry
Following the recent investment announcement, Centauri is pleased to announce that Mike Westby and Pam Brown have joined Centauri Therapeutics. Mike is now Centauri’s Chief…
Centauri Therapeutics closes £24m Series A investment round
Centauri Therapeutics is delighted to announce new investment of £24m in antimicrobial research and appointment of new company directors. See attached press release